Company Filing History:
Years Active: 2006-2008
Title: A Katrina Loomis: Innovator in Epidermal Growth Factor Research
Introduction
A Katrina Loomis is a prominent inventor based in Houston, TX (US), known for her significant contributions to the field of biomedical research. She has been awarded 2 patents for her innovative work, particularly focusing on epidermal growth factor receptor antagonists and agonists.
Latest Patents
Her latest patents include "Epidermal Growth Factor Receptor Antagonists and Methods of Use," which features polypeptide variants of ligands of the epidermal growth factor receptor (EGFR). These antagonists possess properties that can inhibit EGFR-mediated biological activities, such as receptor kinase activation and cell proliferation. This invention holds therapeutic potential in situations where inhibition of EGFR activity is necessary. Another notable patent is "Epidermal Growth Factor Agonists," which presents polypeptides with at least 90% amino acid identity to wild-type epidermal growth factor, exhibiting greater biological activity than the wild-type counterpart.
Career Highlights
A Katrina Loomis is currently associated with Molecular Logix, Inc., where she continues to advance her research in the field. Her work has garnered attention for its potential applications in therapeutic settings, particularly in cancer treatment.
Collaborations
She collaborates with esteemed colleagues, including Wayne M Coco and Philip P Pienkos, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
A Katrina Loomis stands out as a dedicated inventor whose work in epidermal growth factor research has the potential to impact therapeutic strategies significantly. Her contributions to the field exemplify the importance of innovation in biomedical research.